Abstract
The epidemiology of the prostate cancer has radically changed during the last decades, with a tendency to an increasing number of diagnosis and a concomitant reduction of mortality. This is due to both the introduction and the diffusion of PSA as a screening test and the improving of imaging and the standardization of prostate biopsy.
Currently, transrectal ultrasound (TRUS) represents the gold standard radiological exam for prostate imaging because of the best costs/benefits ratio. Nevertheless, it has shown to be not highly accurate (50–60 %), with a low positive predictive value (about 6 %) in the diagnosis of a prostate cancer and with a low reliability in local staging: Thus, the role of TRUS in the evaluation of the prostate in cases of a suspected prostate cancer is still under discussion.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Watanabe H, Kato H, Kato T, Morita M, Tanaka M (1968) Diagnostic application of ultrasonography to the prostrate. Nihon Hinyokika Gakkai Zasshi 59:273–279
Holm HH, Gammelgard J (1981) Ultrasonically guided precise needle placement in prostate and seminal vesicles. J Urol 125:385–387
Onur R, Littrup PJ, Pontes JE, Bianco FJ Jr (2004) Contemporary impact of transrectal ultrasound lesions for prostate cancer detection. J Urol 172:512–514
Patel U, Rickards D (2002) Handbook of transrectal ultrasound and biopsy of the prostate. Martin Dunitz, London
Loch T (2007) Urologic imaging for localised prostate cancer in 2007. World J Urol 25:121–129
Lihrup PJ, Bailey SE (2000) Prostate cancer: the role of transrectal ultrasound and its impact on cancer detection and management. Radiol Clin North Am 38:87–113
Shinohara K, Wheeler TM, Scardino PT (1989) The appearance of prostate cancer on transrectal ultrasonography: correlation of imaging and pathological examinations. J Urol 142:76–78
Hou AH, Swanson D, Barqawi AB (2009) Modalities for imaging of prostate cancer. Adv Urol 81. Article ID 818065
Noh TI, Shin YS, Shim JS, Yoon JH, Kim JH, Bae JH, du Moon G, Park JY (2013) Are hypoechoic lesions on transrectal ultrasonography a marker for clinically significant prostate cancer? Korean J Urol 54(10):666–670
Toi A, Neill M, Lockwood G, Sweet J, Tammsalu L, Fleshner N (2007) The continuing importance of transrectal ultrasound identification of prostatic lesions. J Urol 177:516–520
Raja J, Ramachandran N, Munneke G, Patel U (2006) Current status of transrectal ultrasound-guided prostate biopsy in the diagnosis of prostate cancer. Clin Radiol 61:142–153
Harvey CJ, Pilcher J, Richenberg J, Patel U, Frauscher F (2012) Applications of transrectal ultrasound in prostate cancer. Br J Radiol 85:S3–S17
Patel U (2011) The prostate and seminal vesicles. In: Allan P, Baxter G, Weston M (eds) Clinical ultrasound, 3rd edn. Churchill-Livingstone, Edinburgh, pp 572–592
Turgut A, Dogra V (2008) Prostatic cancer: evaluation using transrectal sonography. In: Hayat M (ed) Methods of cancer diagnosis, therapy and prognosis. Elvesier, New York, pp 499–520
Halpern E, Strup S (2000) Using gray scale and color and power Doppler sonography to detect prostatic cancer. AJR Am J Roentgenol 174:623–627
Turgut A, Olcucuoglu E, Kosar P, Geyik PO, Kosar U, Dogra V (2007) Power Doppler ultrasonography of the feeding arteries of the prostate gland: a novel approach to the diagnosis of prostate cancer? J Ultrasound Med 26:875–883
Bigler SA, Deering RE, Brawer MK (1993) Comparison of microscopic vascularity in benign and malignant prostate tissue. Hum Pathol 24:220–226
Leen E, Averkiou M, Arditi M, Burns P, Bokor D, Gauthier T et al (2012) Dynamic contrast enhanced ultrasound assessment of the vascular effects of novel therapeutics in early stage trials. Eur Radiol 22:1442–1450
Harvey CJ, Pilcher J, Eckersley R, Blomley MJK, Cosgrove DO (2002) Advances in ultrasound. Clin Radiol 57:157–177
Goossen TE, de la Rosette JJ, Hulsbergen-van de Kaa CA, van Leenders GJ, Wijkstra H (2003) The value of dynamic contrast enhanced power Doppler ultrasound imaging in the localization of prostate cancer. Eur Urol 43:124–131
Frauscher F, Klauser A, Volgger H, Halpern EJ, Pallwein L, Steiner H et al (2002) Comparison of contrast-enhanced color Doppler targeted biopsy with conventional systematic biopsy: impact on prostate cancer. J Urol 167:1648–1652
Harvey CJ, Sidhu P (2010) Ultrasound contrast agents in genitourinary imaging. Ultrasound Clin 5:489–506
Scattoni V, Zlotta AR, Nava L, Roscigno M, Montorsi F, Rigatti P (2002) Prostatic transrectal ultrasound (TRUS) guided biopsy schemes and TRUS prostatic lesion-guided biopsies. Eur Urol Suppl 1(6):28–34
Melchior SW, Brawer MK (1996) Role of transrectal ultrasound and prostate biopsy. J Clin Ultrasound 24:463–471
Fleshner NE, O’Sullivan M, Premdass C, Fair WR (1999) Clinical significance of small (less than 0.2 cm3) hypoechoic lesions in men with normal digital rectal examinations and prostate-specific antigen levels of less than 10 ng/ml. Urology 53:356–358
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Scattoni, V., Maccagnano, C., Roscigno, M. (2017). Prostatic Carcinoma. In: Martino, P., Galosi, A. (eds) Atlas of Ultrasonography in Urology, Andrology, and Nephrology. Springer, Cham. https://doi.org/10.1007/978-3-319-40782-1_24
Download citation
DOI: https://doi.org/10.1007/978-3-319-40782-1_24
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-40780-7
Online ISBN: 978-3-319-40782-1
eBook Packages: MedicineMedicine (R0)